Latest / The Founder's Journey with Fexingo: First-Time Entrepreneurs, Failures, and Lessons Learned
How a Rejected Patent Built a 50M Medical Device Company
Dr. Sarah Chen filed a patent for a non-invasive glucose monitor, but the patent office rejected it due to prior art. Instead of giving up, she realized the same sensor technology could detect early-stage kidney disease by measuring creatinine levels. She pivoted her startup, NephroSense, and after a rocky FDA approval process, the company was acquired for $50 million by a major medtech firm. In this episode, Lucas and Luna unpack the lesson: your rejection is often a redirection to a bigger problem. They also discuss how Chen convinced her first investor after 37 rejections, and why she says…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.